Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial
source: pixabay.com

Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial

Pyoderma gangraenosum (PG) is a rare auto inflammatory disease which affects the skin. It unfortunately has no currently approved therapies. However, recent preliminary results from a Phase 2a trial have…

Continue Reading Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial

Patient Dosing Begins in VIITAL Study of EB-101, a Treatment for Recessive Dystrophic Epidermolysis Bullosa

The first patient has been dosed in the third phase of the VIITAL study, which is intended to evaluate the effectiveness of EB-101. This medication is a gene-corrected cell therapy…

Continue Reading Patient Dosing Begins in VIITAL Study of EB-101, a Treatment for Recessive Dystrophic Epidermolysis Bullosa
He Faced Death Multiple Times From iMCD But David Fajgenbaum Will Not Give Up
source: pixabay.com

He Faced Death Multiple Times From iMCD But David Fajgenbaum Will Not Give Up

  To celebrate Rare Disease Day and raise awareness for approximately seven thousand rare diseases, Dr. Francis Collins, director of the National Institutes of Health, recently interviewed a person he…

Continue Reading He Faced Death Multiple Times From iMCD But David Fajgenbaum Will Not Give Up